Animal and Translational Models for CNS Drug Discovery: Neurological Disorders (Animal and Translational Models for Cns Drug Discovery): 2

5 avg rating
( 1 ratings by GoodReads )
 
9780123738554: Animal and Translational Models for CNS Drug Discovery: Neurological Disorders (Animal and Translational Models for Cns Drug Discovery): 2

"Neurological Disorders" is written for researchers in both academia and the pharmaceutical industry who use animal models in research and development of drugs for neurological disorders such as neurofibromatosis, Alzheimer's disease, Parkinson's disease, Huntington disease, ALS, and the epilepsies. "Neurological Disorders" has introductory chapters expressing the view of the role and relevance of animal models for drug discovery and development for the treatment of psychiatric disorders from the perspective of: academic basic neuroscientific research, applied pharmaceutical drug discovery and development, and issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in each therapeutic area covered and discuss the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on "Animal and Translational Models for CNS Drug Discovery" is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This is the second volume in the three volume-set, "Animal and Translational Models for CNS Drug Discovery" (9780123738615), which is also available for purchase individually. It feature: clinical, academic, government and industry perspectives fostering integrated communication between principle participants at all stages of the drug discovery process; critical evaluation of animal and translational models improving transition from drug discovery and clinical development; emphasis on what results mean to the overall drug discovery process; and, exploration of issues in clinical trial design and conductance in each therapeutic area.

"synopsis" may belong to another edition of this title.

About the Author:

Dr. McArthur began his professional career investigating the role of serotonin on feeding behaviour at the Clarke Institute of Psychiatry in Toronto, Canada. This interest led him to complete a PhD in the psychopharmacology of feeding behaviour and macronutrient selection with John Blundell at the University of Leeds, Leeds, UK. In 1981 he joined Beecham Pharmaceuticals to work on adrenergic involvement in energy expenditure and obesity. In 1983 Dr McArthur began working on M1 functional agonists for the treatment of Alzheimer disease and was responsible for demonstrating the initial procognitive effects of Sabcomeline. Following the merger of Beecham with SmithKline French, Dr McArthur was appointed Business Development Executive at I.T.E.M-Labo, Paris working with Roger Porsolt in behavioural pharmacology contract research. In 1992, Robert was appointed Head of Behavioral Pharmacology at Farmitalia Carlo Erba, later Pharmacia in Milan. His lab was responsible for the preclinical behavioural pharmacology of Sabcomeline (Alzheimer's and schizophrenia); Safinamide (epilepsy and Parkinson's); Reboxetine (depression); Cabergoline (Parkinson's); Nicergoline (Mild Cognitive Impairment); and Amperozide (alcoholism). He is listed as an inventor in 19 issued patents and applications of which he is the principal inventor in 3. In 1998, Robert transferred to the Pharmacia and Upjohn Company in Kalamazoo, Michigan where as senior behavioural pharmacologist responsible, he worked on mutant mouse characterizations, the establishment of a primate unit assessing cognitive changes in monkeys (CANTAB), and development of anxiety models in marmosets. Soon after the merger of Pharmacia and Upjohn with Monsanto-Searle, Robert returned to Europe where in 2001 he founded the consulting company, McArthur and Associates GmbH in Basel. Robert has since worked on a series of projects for both large Pharma as well as biotechs, including further primate work in Parkinson's, development of behavioural pharmacology expertise, novel target validation, due diligence, medical writing, strategy evaluation, scientific advisor and as an expert witness. Dr McArthur has pursued his academic interests in translational neuroscience. In 2003, Robert was appointed as a visiting Associate Research Professor in the Department of Neuroscience (Division of Behavioural Neuroscience) at the Karolinska Institute in Stockholm. He has written and co-edited extensively on the subject of the clinical and translational relevance of animal models of CNS disorders. He has authored 43 peer-reviewed papers, 13 book chapters, co-author on 1 book and senior editor of a three-volume set on translational value of animal models for CNS drug discovery. He has served as section editor (CNS) for Current Opinion in Investigational Drugs and is on the editorial board of Drugs of the Future. In 2009 he was appointed an independent scientific expert evaluator for the European FP7-Health call. Franco Borsini, Head, Central & Peripheral Nervous System and General Pharmacology Area - R&D Department, sigma-tau SpA, Pomezia (Rome), Italy

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Robert A. McArthur, Franco Borsini
Published by Academic Press 2008-11-18 (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 5
Seller
Chiron Media
(Wallingford, United Kingdom)
Rating
[?]

Book Description Academic Press 2008-11-18, 2008. Hardcover. Book Condition: New. Bookseller Inventory # NU-ELS-00003009

More Information About This Seller | Ask Bookseller a Question

Buy New
47.24
Convert Currency

Add to Basket

Shipping: 2.49
Within United Kingdom
Destination, Rates & Speeds

2.

Robert A. McArthur
Published by Elsevier Science Publishing Co Inc, United States (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2008. Hardback. Book Condition: New. 259 x 190 mm. Language: English . Brand New Book. Neurological Disorders is written for researchers in both academia and the pharmaceutical industry who use animal models in research and development of drugs for neurological disorders such as neurofibromatosis, Alzheimer s disease, Parkinson s disease, Huntington disease, ALS, and the epilepsies. Neurological Disorders has introductory chapters expressing the view of the role and relevance of animal models for drug discovery and development for the treatment of psychiatric disorders from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in each therapeutic area covered and discuss the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This is the second volume in the three volume-set, Animal and Translational Models for CNS Drug Discovery 978-0-12-373861-5, which is also available for purchase individually. Bookseller Inventory # AA59780123738554

More Information About This Seller | Ask Bookseller a Question

Buy New
51.10
Convert Currency

Add to Basket

Shipping: FREE
Within United Kingdom
Destination, Rates & Speeds

3.

Robert A. McArthur
Published by Elsevier Science Publishing Co Inc, United States (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Elsevier Science Publishing Co Inc, United States, 2008. Hardback. Book Condition: New. 259 x 190 mm. Language: English . Brand New Book. Neurological Disorders is written for researchers in both academia and the pharmaceutical industry who use animal models in research and development of drugs for neurological disorders such as neurofibromatosis, Alzheimer s disease, Parkinson s disease, Huntington disease, ALS, and the epilepsies. Neurological Disorders has introductory chapters expressing the view of the role and relevance of animal models for drug discovery and development for the treatment of psychiatric disorders from the perspective of (a) academic basic neuroscientific research, (b) applied pharmaceutical drug discovery and development, and (c) issues of clinical trial design and regulatory agencies limitations. Each volume examines the rationale, use, robustness and limitations of animal models in each therapeutic area covered and discuss the use of animal models for target identification and validation. The clinical relevance of animal models is discussed in terms of major limitations in cross-species comparisons, clinical trial design of drug candidates, and how clinical trial endpoints could be improved. The aim of this series of volumes on Animal and Translational Models for CNS Drug Discovery is to identify and provide common endpoints between species that can serve to inform both the clinic and the bench with the information needed to accelerate clinically-effective CNS drug discovery. This is the second volume in the three volume-set, Animal and Translational Models for CNS Drug Discovery 978-0-12-373861-5, which is also available for purchase individually. Bookseller Inventory # AA59780123738554

More Information About This Seller | Ask Bookseller a Question

Buy New
53.39
Convert Currency

Add to Basket

Shipping: FREE
Within United Kingdom
Destination, Rates & Speeds

4.

Mcarthur, Robert A. (Editor)/ Borsini, Franco (Editor)
Published by Academic Pr (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 2
Seller
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Academic Pr, 2008. Hardcover. Book Condition: Brand New. 1st edition. 361 pages. 10.25x7.25x1.00 inches. In Stock. Bookseller Inventory # __0123738555

More Information About This Seller | Ask Bookseller a Question

Buy New
61.84
Convert Currency

Add to Basket

Shipping: 2.75
Within United Kingdom
Destination, Rates & Speeds

5.

MCARTHUR, ROBERT; BORSINI, FRANCO
Published by Academic Press (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Academic Press, 2008. Hardback. Book Condition: NEW. 9780123738554 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0891841

More Information About This Seller | Ask Bookseller a Question

Buy New
63
Convert Currency

Add to Basket

Shipping: 3.75
Within United Kingdom
Destination, Rates & Speeds

6.

MCARTHUR, ROBERT; BORSINI, FRANCO
Published by Academic Press (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Academic Press, 2008. Hardback. Book Condition: NEW. 9780123738554 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE01196109

More Information About This Seller | Ask Bookseller a Question

Buy New
63
Convert Currency

Add to Basket

Shipping: 3.75
Within United Kingdom
Destination, Rates & Speeds

7.

Robert A. McArthur
Published by Academic Press (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Academic Press, 2008. Hardcover. Book Condition: New. book. Bookseller Inventory # 0123738555

More Information About This Seller | Ask Bookseller a Question

Buy New
75.34
Convert Currency

Add to Basket

Shipping: 5.29
From U.S.A. to United Kingdom
Destination, Rates & Speeds

8.

Robert A. McArthur
Published by Academic Press (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 3
Seller
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Academic Press, 2008. Hardcover. Book Condition: New. Bookseller Inventory # P110123738555

More Information About This Seller | Ask Bookseller a Question

Buy New
66.42
Convert Currency

Add to Basket

Shipping: 16.03
From U.S.A. to United Kingdom
Destination, Rates & Speeds

9.

Robert A. McArthur (Editor), Franco Borsini (Editor)
Published by Academic Press (2008)
ISBN 10: 0123738555 ISBN 13: 9780123738554
New Hardcover Quantity Available: 1
Seller
Ergodebooks
(RICHMOND, TX, U.S.A.)
Rating
[?]

Book Description Academic Press, 2008. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX0123738555

More Information About This Seller | Ask Bookseller a Question

Buy New
93.13
Convert Currency

Add to Basket

Shipping: 11.23
From U.S.A. to United Kingdom
Destination, Rates & Speeds